Norte (PT11)

Innovation Performance Group (2019) : Strong -

Total population (2019) 3572583

Population per km² (2017) 170

Proportion population older 65 year % 20,47%

Regional webiste


Health Cluster Portugal

www.healthportugal.com


Background


Norte or Northern Portugal is the most populous region in Portugal, ahead of Lisboa, with a population of 3.7 million. Portugal has a vibrant and innovative research and development ecosystem and a high quality health care system.


Under the auspices of the Health Cluster Portugal (HCP), the Portuguese "Health ecosystem" is developing innovative projects in areas which include active and healthy ageing, translational and clinical research, ambient assisted living, eHealth, and health tourism. Particular strategic areas of interest include preventative, personalised and participatory medicine (diseases - neurodegenerative, cancer, cardiovascular, degenerative osteoarticular, inflammatory, infectious, metabolic).

 

Within Portugal universities, R&D institutions, hospitals and companies are all working in collaboration in the development of new solutions for improving human health.


Is the region looking for international/European/interregional collaboration opportunities? 


Yes - H2020 projects, NIH projects.


Membership status


Member ICPerMed? no 

Mountain ? > 50 % of surface in mountain areas

Member Euregha? no 

Adriatic-Ionian MacroRegion? no

InnoStars Region? no 

Northern Sparsely Populated Area (NSPA)? no

PM region according EC? no 

Baltic Sea MacroRegion? no

S3MedTech region? no 

Danube MacroRegion? no

S3P4PM region? no 

Alpine MacroRegion? no

Regions4PM region? no

S3ClusSport member? no 

Central Europe? no

MedTech4Europe? no

Council of European BioRegions (CEBR)? no

European Regions Research & Innovation Network (ERRIN)?  no

Vanguard Initiative? yes

ERAPerMed? no



Policy documents

 

  1. National level: Thematic Agenda for Research and Innovation on Health, Clinical and Translational Research  

  2. National level: Strategy for Research and Innovation for Smart Specialisation

  3. National level: Basic Law of Health  


Topics covered by policies : Population genomics initiative (cfr 1 million genomes participation); Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Education, training and skill development; Prediction and prevention; ICT/genomics, health, lifestyle data(infrastructure)


NACE Personalised Medicine/Personalised Health  elated to Research and Innovation objectives:

C.21 - Basic pharmaceutical products and   pharmaceutical preparations; C.32 - Other manufacturing; Q.86 - Human health   activities; M.72 - Scientific research and development


Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS07 - Health; NABS133 - R&D related to   Medical Sciences - financed from other sources than GUF


Policy objective Personalised   Medicine/Personalised Health related related to Research and Innovation objectives: H.51 - New or improved organisational models

Policy document (RIS3): Yes

Policy document PM@RIS3:  Yes - Health and Life Sciences: Consolidate links between research and business, especially in the areas of tissue engineering, cancer, neurosciences and surgical procedures

Major initiatives

 

  1. The Discoveries Centre for Regenerative and Precision Medicine

  2. Project DOCnet  

  3. Project SIRNAC - Novel siRNA Therapies Against Metastatic Colorectal Cancer

  4. CHUSJ - Centro Hospitalar Universitário de São João, inical Academic Center

  5. CHUP - Centro Hospitalar Universitário do Porto, inical Academic Center  

  6. 2CA-Braga - Clinical Academic Center – BragaClinical Academic Center

  7. IPO-Porto Onology Hospital

  8. i3S esearch Institute

  9. The Discoveries Centre for Regenerative and Precision Medicine 

  10. CeLac and European consortium for a personalized medicine approach to Gastric Cancer: LEGACY project 

  11. Analysis and correlation between the complete genome and brain activity for help in the diagnosis of Alzheimer's disease 

  12. BIOLOGIC@ - Une perspective BioÉconomique du Futur

  13. Blue biotechnology as a road for innovation on human’s health aiming smart growth in Atlantic Area 

  14. Digital Innovation Hubs:

 

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?

 

  1. CeLac and European consortium for a personalized medicine approach to Gastric Cancer: LEGACY project


Self evaluation


General perception of the implementation level of PM in the region -  Medium

Rate of the need for developing and implementing PM in the region - High

Rate of the need for increasing support/funding for PM activities in the  region - High

Rate of the need for increasing the capacity of PM skills in the region - Medium

Rate of the genomics literacy of the citizens in the region - Low

Rate of the need for increasing interregional collaboration in PM - High

Image attribution

Picture2.png
SHAPIRE SOCIAL ICONS-3.jpg
SHAPIRE SOCIAL ICONS-2.jpg
SHAPIRE SOCIAL ICONS-4.jpg

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium